The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
about
The role of hyperosmotic stress in inflammation and diseaseNeuroprotection as a Therapeutic Target for Diabetic RetinopathyThe role of aflibercept in the management of diabetic macular edemaCellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesMetabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom controlMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsThe Role of Cys-298 in Aldose Reductase FunctionIdentification of Novel Aldose Reductase Inhibitors from Spices: A Molecular Docking and Simulation StudyRetinal insulin receptor signaling in hyperosmotic stressAldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.Phospho-Site-Specific Antibody Microarray to Study the State of Protein Phosphorylation in the Retina.Early hepatic insulin resistance in mice: a metabolomics analysis.Metabolome and proteome changes with aging in Caenorhabditis elegans.Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?Interruption of Wnt signaling in Müller cells ameliorates ischemia-induced retinal neovascularization.Different experimental approaches in modelling cataractogenesis: An overview of selenite-induced nuclear cataract in rats.Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.Pathophysiology and treatment of diabetic retinopathy.Novel drugs and their targets in the potential treatment of diabetic retinopathy.Lithium induces ER stress and N-glycan modification in galactose-grown Jurkat cells.Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders.Endothelial cell metabolism in normal and diseased vasculature.Diabetic retinopathy, superoxide damage and antioxidants.Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells.Dietary advanced glycation end products and aging.Role of Cytochrome Modulators in Altering the Occurrence of Cataract in RatsReduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic ratsClinical biomarkers and molecular basis for optimized treatment of diabetic retinopathy: current status and future prospects.Aldose reductase-mediated induction of epithelium-to-mesenchymal transition (EMT) in lensCorrelation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy.A Genome-Wide Association Study Provides New Evidence That CACNA1C Gene is Associated With Diabetic CataractMetabolomics in diabetic complications.Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway.Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients.The renal effects of blood glucose-lowering plant-derived extracts in diabetes mellitus--an overview.Retinal pigment epithelium differentiation of stem cells: current status and challenges.Current approaches to the management of diabetic retinopathy and diabetic macular oedema.The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.
P2860
Q24602948-75B31EF9-189F-448C-A8C6-8D75D1202D5CQ26749178-4357F4FE-8C55-4E2B-92FD-CC351683F53BQ26798348-73E02DFB-C38F-40B5-A6DD-DD7FFE03FB34Q26798487-771931AC-4F38-4CF7-A605-9C3FD397E103Q26852079-313336DA-DC03-4151-A9E1-2B4738855421Q27014620-225285D8-1171-4BCD-ABFC-D469EDF6ECB8Q27665951-08E4A983-C9EF-4FDA-9838-D291A0117FD6Q28548260-C8EAB58C-2F72-4294-A62F-9BEDDC7AD5CAQ28568662-89457F84-4F80-45BA-8A1C-F1C3183D9D8CQ33567452-29A1A521-0F97-4A54-A6F1-9160309FBCDCQ33642984-FF328DB4-E05D-4807-AE1E-1C2D91CA1CF3Q33735936-80C6FBA8-56A3-48F0-9E49-762F4C280C4AQ33807271-5CF268E5-9BB8-4BBA-B1A1-0C985B0545ECQ33887865-46FB10A2-BCC7-45A4-868C-80A4D658CAB6Q34278108-64E4AFA7-14F9-43B9-B792-D2CE165CD057Q34320089-41D7A253-EE77-4E7A-8E2E-87DFDFA50E1FQ34452521-7498C921-A44C-4370-8356-1EF78C3CAE51Q34528134-5414FD5E-6FD6-4A8E-AFA3-D26F5BA94C4FQ34688209-3FDDC3AE-088D-424A-BFE4-16C37B9A9B9BQ34876367-E4C223B0-749A-407E-982E-6C655524676CQ35012014-EEC19BC0-9C43-4A47-94E3-FDEC8E0B6759Q35234625-B85B7C4A-3037-4FC4-A728-41F000BC75E5Q35545811-560D4539-2CE6-499C-A000-E6102E73E1A9Q35551436-A7DA4077-8BCD-4AC7-AF8B-CDE24DC0496EQ35670859-72B971B7-ABB2-43D4-ABC0-F58640166064Q36068093-7B356F56-8CD7-4A64-B5F7-E081ADDAD279Q36325522-EA06B246-6514-4372-A5A1-56EAA345DFD1Q36379507-89101EDD-DEF6-44BD-B5DC-93A5F98CCA0AQ36618824-CDFFD8EB-F259-4CC3-B19C-6A71C34830BFQ36728262-F0B0837C-6BB0-4F14-BB53-D601925BF058Q36867006-ECADF1C8-CCD4-4F9C-AE96-A6F04B2E6289Q37041169-7FC64085-6641-4BF8-969A-1E212E0C449EQ37226580-52EB30CA-771D-4A3F-9071-79B88621852FQ37258582-B3D184B7-A865-4884-ADB7-8AE8DF0A34B4Q37292061-DF98858B-EEF3-4995-9774-76AC5CBC56A8Q37683784-2DF1D0DA-A7CE-4D3E-802C-32C788A306ACQ37763230-78A2E932-3ECA-4819-8C7F-4112F31F3338Q37801912-0B4FA58E-ED53-4DD0-BAE3-9B388692D0DFQ37970585-D66BE66F-F183-4F02-B199-0BE15E7DB7BAQ38620860-356159D4-29CF-4A85-B1F4-6FFDBA4E1093
P2860
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@en
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@nl
type
label
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@en
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@nl
prefLabel
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@en
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@nl
P2860
P921
P356
P1476
The polyol pathway as a mechan ...... ctive, elusive, and resilient.
@en
P2093
Mara Lorenzi
P2860
P356
10.1155/2007/61038
P5008
P577
2007-01-01T00:00:00Z